Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

Flora Growth to acquire German medical cannabis distributor

Flora Growth Corp. has signed a definitive agreement to acquire 100% of Franchise Global Health Inc., a multi-national operator in the medical cannabis and pharmaceutical industry with principal operations in Germany.

"Through this proposed acquisition, we are connecting our commercial infrastructure and medical cannabis product portfolio to the German and EU medical markets while gaining direct access to European pharmaceutical distributions," said Luis Merchan, Chairman and CEO of Flora Growth. "We believe Franchise will significantly increase our international commercial revenue and provide essential distribution to German pharmacies and a growing wholesale market."

FGH's German reportable segment achieved revenues of CA$30.1 million, gross profit of CA$2.1 million, and net income of CA$0.4 million in the first half of 2022 1 . FGH's German businesses operate primarily in the export pharmaceutical and medical cannabis import and distribution markets, servicing 1,200 pharmacies in Germany and providing non-cannabis medical products to 28 additional countries.

This acquisition is expected to accelerate Flora's expansion into the European cannabis and pharmaceutical markets with prescription medicines and would provide the Company with immediate access to a wealth of knowledge and intellectual property that FGH has developed, including 41 registered cannabis strains in Colombia and the first registered cannabis seed bank in Copenhagen, Denmark housing 286 strains. The proposed acquisition would further allow Flora to expand its CBD business in Europe by utilizing FGH's distribution and logistics capabilities.

The combination of Flora and FGH is expected to deliver at least US$3.0 million of annualized cost synergies within the first year following the completion of the acquisition, primarily in the areas of reduced corporate administrative expenses.

"Luis and I share the same vision of establishing a leading and sustainable cannabis business. Flora has the right platform to execute this strategy through M&A and organic growth. We are excited to join forces," says Clifford Starke, CEO and Executive Chairman of FGH. "Together, we have a solid revenue base, a proven consumer packaged goods business that can be replicated in Europe, and a successful distribution network. Over the past few months, we have worked tirelessly to identify synergies, reduce costs, and build an industry-leading team."

For more information:
Flora Growth  
[email protected] 
www.floragrowth.ca  

Publication date: